WHO endorses Chinese Sinovac vaccine for coronavirus

On Tuesday, The World Health Organization approved another Chinese COVID-19 vaccine in hopes of filling the gap of shot supples in developing countries.

ADVERTISEMENT
Image
Hannah Nightingale Washington DC
ADVERTISEMENT

On Tuesday, The World Health Organization approved another Chinese COVID-19 vaccine in hopes of filling the gap of shot supples in developing countries, the Wall Street Journal reports.

CoronaVac, made by the Chinese vaccine maker Sinovac BioTech Ltd., was approved for emergency use., which reportedly opens the doors for Covax, an international body co-led by The WHO, to distribute doses internationally as needed.

"The world desperately needs multiple Covid-19 vaccines to address the huge access inequity across the globe," said the WHO’s assistant-director general for access to health products Dr. Mariângela Simão.

The approval decision marks the seventh vaccine approved by The WHO for global use against COVID-19, and the second Chinese vaccine, behind Sinopharm.

"We urge manufacturers to participate in the Covax Facility, share their know-how and data and contribute to bringing the pandemic under control," said Simão. It is currently unclear when or how many doses the manufacturer will deliver to Covax.

Sinovax’s vaccine approval was initially slowed due to the WHO seeking more data on the vaccine, including data on the safety of the shot and whether its manufacturing processes were compliant with WHO standards.

The vaccine was also met with a rolling review by the European Medicines Agency in the beginning of May.

The WHO cited in its approval of CoronaVac that it has easy storage requirements, allowing for transportation that doesn’t require the vaccine to be refrigerated, like many of its counterparts.

The vaccine, recommended for use for those 18 and older with no upper age limit, prevented symptomatic disease in 51 percent of vaccinated trial participants and prevented severe COVID-19 symptoms and hospitalization in 100 percent of trial participants.

ADVERTISEMENT
ADVERTISEMENT

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2024 The Post Millennial, Privacy Policy | Do Not Sell My Personal Information